Strides Pharma Science Limited — Celecoxib Exporter Profile
Indian Pharmaceutical Exporter · #10 for Celecoxib · $2.8M export value · DGFT Verified
Strides Pharma Science Limited is the #10 Indian exporter of Celecoxib with $2.8M in export value and 92 verified shipments. Strides Pharma Science Limited holds a 2.1% market share in Celecoxib exports across 2 countries. The company exports 42 pharmaceutical products worth $179.3M across 20 therapeutic categories.
Strides Pharma Science Limited — Celecoxib Export Profile: Buyers & Destinations
Where Does Strides Pharma Science Limited Export Celecoxib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $2.1M | 74 | 86.2% |
| SOUTH AFRICA | $328.1K | 18 | 13.8% |
Strides Pharma Science Limited exports Celecoxib to 2 countries. The largest destination is AUSTRALIA accounting for 86.2% of Strides Pharma Science Limited's Celecoxib shipments. These destinations reflect Strides Pharma Science Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Celecoxib from Strides Pharma Science Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APOTEX PTY LTD., | AUSTRALIA | $410.9K | 16 |
| APOTEX PTY LTD | AUSTRALIA | $382.8K | 11 |
| ARROW PHARMACEUTICALS PTY LTD | AUSTRALIA | $328.9K | 10 |
| ARROW PHARMACEUTICALS PTY LTD., | AUSTRALIA | $279.5K | 14 |
| APOTEX PTY LIMITED | AUSTRALIA | $245.3K | 6 |
| APOTEX PTY LTD, | AUSTRALIA | $144.0K | 5 |
| ARROW PHARMACEUTICALS PTY LIMITED | AUSTRALIA | $123.3K | 3 |
| TRINITY PHARMA (PTY)LTD | SOUTH AFRICA | $110.2K | 4 |
| ARROW PHARMACEUTICALS PTY LTD, | AUSTRALIA | $89.8K | 3 |
| TRINITY PHARMA(PTY) LTD. | SOUTH AFRICA | $79.7K | 3 |
Strides Pharma Science Limited supplies Celecoxib to 14 buyers globally. The largest buyer is APOTEX PTY LTD., (AUSTRALIA), followed by APOTEX PTY LTD (AUSTRALIA) and ARROW PHARMACEUTICALS PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Celecoxib Export Value and How Much Does Strides Pharma Science Limited Contribute?
India exported $62.9M worth of Celecoxib through 4,880 shipments from 326 suppliers to 112 countries, serving 781 buyers globally. Strides Pharma Science Limited contributes $2.8M to this total, accounting for 2.1% of India's Celecoxib exports. Strides Pharma Science Limited ships Celecoxib to 2 countries through 14 buyers.
What Is the Average Shipment Value for Strides Pharma Science Limited's Celecoxib Exports?
Strides Pharma Science Limited's average Celecoxib shipment value is $30.8K per consignment, based on 92 shipments totaling $2.8M. The largest destination is AUSTRALIA (86.2% of Strides Pharma Science Limited's Celecoxib exports).
How Does Strides Pharma Science Limited Compare to Other Indian Celecoxib Exporters?
Strides Pharma Science Limited ranks #10 among 326 Indian Celecoxib exporters with a 2.1% market share. The top 3 exporters are ALEMBIC PHARMACEUTICALS LIMITED ($12.2M), CIPLA LIMITED ($12.2M), MACLEODS PHARMACEUTICALS LTD ($9.2M). Strides Pharma Science Limited processed 92 shipments to 2 destination countries.
What Celecoxib Formulations Does Strides Pharma Science Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CELECOXIB WGR CELECOXIB CAPSULES 100MG 59 334 00 X 6 X 10S | $100.0K | 2 |
| APX- CELECOXIB Celecoxib Capsules 100mg4 | $98.4K | 2 |
| ANABREX 200 CELECOXIB CAPSULES 200 MG (4 | $95.6K | 2 |
| APX - CELECOXIB, CELECOXIB CAPSULES 100M | $73.8K | 2 |
| APX- CELECOXIB Celecoxib Capsules 100mg40,075.00X 6X10S | $73.2K | 2 |
| APX- CELECOXIB Celecoxib Capsules 100mg | $71.2K | 3 |
| CELECOXIB CAPSULES 200MG 60,317.00X 3X10SNOS | $53.1K | 3 |
| APX - CELECOXIB, CELECOXIB CAPSULES 200M | $51.5K | 2 |
| Celecoxib Capsules 200mg 59,202.00X 3X10 | $50.0K | 1 |
| APX CELECOXIB CELECOXIB CAPSULES 200MG9 58285 X 3 X 10 S | $50.0K | 1 |
Strides Pharma Science Limited exports 65 distinct Celecoxib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CELECOXIB WGR CELECOXIB CAPSULES 100MG 59 334 00 X 6 X 10S with 2 shipments worth $100.0K.
Regulatory Requirements: Exporting Celecoxib to Key Markets
What Strides Pharma Science Limited must comply with to export Celecoxib to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Strides Pharma Science Limited Compare to Nearest Celecoxib Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | UMEDICA LABORATORIES PRIVATE LIMITED | $3.3M | 65 | 2 | $50.0K |
| 9 | APOTEX RESEARCH PRIVATE LIMITED | $3.2M | 77 | 3 | $41.1K |
| 10 | STRIDES PHARMA SCIENCE LIMITED ★ | $2.8M | 92 | 2 | $30.8K |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $2.8M | 127 | 9 | $22.0K |
| 12 | EMCURE PHARMACEUTICALS LIMITED | $2.3M | 146 | 1 | $15.7K |
Strides Pharma Science Limited ranks #10 among 326 Indian Celecoxib exporters. Average shipment value of $30.8K compared to the market average of $192.8K. The closest competitors by value are UMEDICA LABORATORIES PRIVATE LIMITED and APOTEX RESEARCH PRIVATE LIMITED.
Which Indian Ports Ship Celecoxib Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 544 | 11.1% |
| DELHI AIR CARGO ACC (INDEL4) | 475 | 9.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 433 | 8.9% |
| SAHAR AIR | 323 | 6.6% |
| JNPT/ NHAVA SHEVA SEA | 305 | 6.3% |
| DELHI AIR | 256 | 5.2% |
| JNPT | 216 | 4.4% |
| MUNDRA SEA | 196 | 4.0% |
What Other Analgesics & Antipyretics Products Does Strides Pharma Science Limited Export?
Strides Pharma Science Limited also exports these analgesics & antipyretics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Strides Pharma Science Limited's Celecoxib Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Strides Pharma Science Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, a critical shipping route. This situation has resulted in higher shipping costs and potential delays, impacting the timely delivery of pharmaceutical products to key markets.
Conversely, ongoing trade tensions between the U.S. and China have opened avenues for Indian pharmaceutical companies. The U.S. is increasingly looking towards India as a reliable supplier of generic drugs, providing companies like Strides with opportunities to expand their footprint in the American market.
In the European Union, the implementation of the Falsified Medicines Directive (FMD) has imposed stringent compliance requirements. Indian exporters must adapt to these regulations to maintain market access. However, the recent India–EU Free Trade Agreement, concluded in January 2026, aims to eliminate tariffs on pharmaceuticals, potentially enhancing the competitiveness of Indian exporters in the European market. (en.wikipedia.org)
Strides Pharma Science Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Strides Pharma Science Limited has demonstrated a commitment to quality, as evidenced by the U.S. FDA's classification of its Chestnut Ridge facility in New York as "Voluntary Action Indicated" following an inspection in December 2025. This classification indicates that while some observations were noted, they are not expected to lead to regulatory action, reflecting the facility's adherence to Good Manufacturing Practices. (economictimes.indiatimes.com)
Such regulatory approvals are crucial for sustaining and expanding market presence, particularly in stringent markets like the U.S. and the EU. Continuous investment in compliance and quality assurance will be essential for Strides to navigate the evolving regulatory landscape effectively.
About Strides Pharma Science Limited
Strides Pharma Science Limited exports 42 products worth $179.3M. Beyond Celecoxib, top products include Ibuprofen, Rosuvastatin, Gabapentin, Vancomycin, Prednisone. View the complete Strides Pharma Science Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Celecoxib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Celecoxib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Strides Pharma Science Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 92 individual customs records matching Strides Pharma Science Limited exporting Celecoxib, covering 65 formulations to 2 countries via 14 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 112+ countries, 781+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Celecoxib Export Data from Strides Pharma Science Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Strides Pharma Science Limited's Celecoxib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Strides Pharma Science Limited
Full Company Profile →
42 products · $179.3M total trade · 20 categories
Celecoxib Stats
Company Overview
Top Products by Strides Pharma Science Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Strides Pharma Science Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Celecoxib. For current shipment-level data, contact TransData Nexus.